/term/accounts-payable/XKRX:203400 ABION (XKRX:203400) Accounts Payable
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » ABION Inc (XKRX:203400) » Definitions » Accounts Payable

ABION (XKRX:203400) Accounts Payable : ₩0 Mil (As of Mar. 2024)


View and export this data going back to 2014. Start your Free Trial

What is ABION Accounts Payable?

ABION's Accounts Payable for the quarter that ended in Mar. 2024 was ₩0 Mil.


ABION Accounts Payable Historical Data

The historical data trend for ABION's Accounts Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

ABION Accounts Payable Chart

ABION Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Accounts Payable
Get a 7-Day Free Trial Premium Member Only 1,015.45 - - - -

ABION Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Accounts Payable Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

ABION Accounts Payable Calculation

Accounts Payable represents any money that a company owes its suppliers for goods and services purchased on credit and is expected to pay within the next year or operating cycle.


ABION Accounts Payable Related Terms

Thank you for viewing the detailed overview of ABION's Accounts Payable provided by GuruFocus.com. Please click on the following links to see related term pages.


ABION (XKRX:203400) Business Description

Traded in Other Exchanges
N/A
Address
9th FI, HanWha Biz Metro Building, 242 Digital-ro, Guro-gu, Seoul, KOR, 08394
ABION Inc is a biopharmaceutical company. It is primarily involved in the research and development new bio pharmaceutical drugs and companion diagnostics systems for the treatment of incurable diseases.

ABION (XKRX:203400) Headlines

No Headlines